BerGenBio ASA
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of BerGenBio ASA generated cash of -$225,101,000, which is more than the previous year. Cash used in financing activities reached the amount of $224,884,000 last year. Net change in cash is therefore $5,618,000.
Cash Flow
| 2014 | -53.71M | 0 | 167.95M |
|---|---|---|---|
| 2015 | -62.90M | 0 | 10.53M |
| 2016 | -124.31M | -255K | 212.40M |
| 2017 | -168.10M | -340K | 376.97M |
| 2018 | -186.70M | -228K | 176.99M |
| 2019 | -184.14M | 0 | 77.31M |
| 2020 | -234.29M | 3.54M | 699.50M |
| 2021 | -303.34M | 3.13M | 15.99M |
| 2022 | -288.23M | 3.24M | 2.90M |
| 2023 | -225.10M | 3.05M | 224.88M |
BGBIO.OL Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 150.80M | 436.64M | 721.64M | 253.58M | 360.41M | 370.35M | 161.82M | 73.99M | 126.35M | 12.11M |
Operating activities | ||||||||||
Net income | -190.40M | -302.12M | -309.36M | -257.02M | -199.27M | -191.74M | -182.20M | -129.79M | -72.10M | -57.78M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 223K | 883K | 1.31M | 726K | 785K | 204K | 193K | 207K | 179K | 179K |
Stock-based compensation expense | 3.13M | 3.46M | 7.11M | 7.41M | 3.84M | 0 | 2.31M | 5.70M | 5.57M | 1.98M |
| Deferred income tax benefit | 3.13M | 3.46M | 7.11M | 7.41M | 3.84M | 0 | 2.31M | 5.70M | 5.57M | 1.98M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -1.62M | -3.46M | 1.83M | 1.59M | 2.01M | 0 | -1.12M | 0 | 1.08M | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | -31.80M | 13.64M | 3.27M | 11.98M | 11.15M | 0 | 14.54M | 0 | 1.58M | 0 |
Cash generated by operating activities | -225.10M | -288.23M | -303.34M | -234.29M | -184.14M | -186.70M | -168.10M | -124.31M | -62.90M | -53.71M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | 0 | 0 | -67K | 0 | -228K | -340K | -255K | 0 | 0 |
Acquisitions Net | 0 | 299K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 3.05M | 3.24M | 3.13M | 3.54M | 0 | -228K | -340K | -255K | 0 | 0 |
Financing activities | ||||||||||
Common Stock Issued | 262.04M | 3.21M | 16.62M | 740.85M | 82.78M | 190.52M | 402.29M | 212.22M | 9.23M | 167.95M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.30M | 10.53M | 0 |
Cash used in financing activities | 224.88M | 2.90M | 15.99M | 699.50M | 77.31M | 176.99M | 376.97M | 212.40M | 10.53M | 167.95M |
Net Change In Cash | 5.61M | -285.84M | -284.99M | 468.05M | -106.82M | -9.93M | 208.52M | 87.83M | -52.36M | 114.24M |
Cash at end of period | 156.42M | 150.80M | 436.64M | 721.64M | 253.58M | 360.41M | 370.35M | 161.82M | 73.99M | 126.35M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |